Skip to main content
OpenTrials
Completed

NCT Number: NCT07473661

Human Repeat Insult Patch Test to Evaluate Skin Irritation and Sensitization in Healthy Volunteers

This study evaluates skin irritation and sensitization following repeated application of a collagen-based material in healthy adult volunteers under controlled conditions. Skin responses will be assessed during study participation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

SerenaGroup Monroeville

Monroeville, Pennsylvania, 15146, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 to 70 years
  • Male and female participants
  • Fitzpatrick Skin Types I and VI
  • Participants of any race
  • Participants of any ethnicity (Hispanic or Latino or Not Hispanic or Latino)
  • Generally healthy, without dermatological or systemic conditions that could interfere with study participation or evaluation of results, as determined by the investigator
  • Able to read and understand English and provide written informed consent
  • Able to comply with study procedures and complete all required visits
  • Willing to have test materials applied according to the study protocol
  • Has not participated in a similar clinical study within the previous 30 days
  • Agrees to avoid excessive sun exposure, sunbathing, or tanning during study participation
  • Female participants of childbearing potential willing to undergo pregnancy testing prior to participation
  • Agrees not to change current personal care products during study participation

Exclusion criteria

  • Use of medications that may interfere with study results (e.g., corticosteroids, antihistamines, immunosuppressive agents, or high-dose NSAIDs)
  • History of acute or chronic medical conditions that could interfere with study participation or increase risk (e.g., autoimmune disease, HIV infection)
  • Chronic skin conditions such as atopic dermatitis or eczema
  • Treatment for skin cancer within the previous 12 months
  • Abnormal or damaged skin at test sites that could interfere with evaluation (e.g., sunburn, tattoos, scars, active dermatologic conditions)
  • Diabetes requiring insulin therapy
  • Pregnant, planning pregnancy, or breastfeeding
  • Known hypersensitivity to personal care products, cosmetics, fragrances, or adhesives
  • Known fish allergy
  • Any condition that, in the opinion of the investigator, may compromise participant safety or study integrity

Treatment and study plan

Collagen-Based Material

Device

A collagen-based material applied under occlusive patch conditions to assess skin irritation and sensitization in healthy adult participants.

Primary outcomes

  1. Dermal Irritation Score Using the International Contact Dermatitis Research Group (ICDRG) Scale

    Time frame: During the induction phase (approximately 3 consecutive weeks)

    Dermal irritation response will be assessed using the International Contact Dermatitis Research Group (ICDRG) skin reaction grading scale (0-4).

Secondary outcomes

  1. Allergic Contact Sensitization Response Using ICDRG Scale

    Time frame: Through completion of all skin assessments during the study (approximately 5-6 weeks)

    Allergic contact sensitization response will be assessed using the International Contact Dermatitis Research Group (ICDRG) skin reaction grading scale (0-4) following challenge exposure

Sponsors and collaborators

Lead sponsor

SerenaGroup, Inc.

Network

Registry information

Official study title

Human Repeat Insult Patch Test (HRIPT): Assessment of Skin Irritation and Sensitization of a Collagen-Based Material in Healthy Volunteers

Acronym: HRIPT

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Mar 16, 2026
Registry last updated
May 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.